Subtyping of non-small cell lung cancer can be challenging based on pathology. Here, the authors utilise multi-omics analysis of 229 patients to identify further subtypes, and altered immune composition between subtypes.
- Kyu Jin Song
- Seunghyuk Choi
- Kwang Pyo Kim